The SIDER database of drugs and side effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most widely utilized ADE databases derived from drug label data is SIDER, constructed using a dictionary-based named entity recognition (NER) method to extract adverse event terms from FDA Structured Product Labeling (SPLs) drug labels13.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Self-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, it was shown that ADRs can be used to predict drug targets (1) and that causal relations between targets and ADRs can be elucidated (2,3).”
BackgroundSelf-citationThe Stanford typed dependencies representation
de Marneffe, M.-C., & Manning, C. D. (2008) · Coling 2008: Proceedings of the workshop on Cross-Framework and Cross-Domain Parser Evaluation - CrossParser '08 · doi:10.3115/1608858.1608859 · Cited by 918
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Self-citationPREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Self-citationExtraction of potential adverse drug events from medical case reports
Gurulingappa, H., Mateen‐Rajpu, A., & Toldo, L. (2012) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-3-15 · Cited by 211
The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text
Pafilis, E., Frankild, S. P., Fanini, L., Faulwetter, S., Pavloudi, C., Vasileiadou, A., Arvanitidis, C., & Jensen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065390 · Cited by 206
Self-citationCai, M., Xu, Q., Pan, Y.-J., Pan, W., Ji, N., Li, Y.-B., Jin, H.-J., Liu, K., & Ji, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1066 · Cited by 131
Systematic identification of proteins that elicit drug side effects
Kuhn, M., Al Banchaabouchi, M., Campillos, M., Jensen, L. J., Gross, C., Gavin, A., & Bork, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 120
Self-citation
Cited by
Items 101–200 of 1,001
Kim, H., Kim, E., Lee, I., Bae, B., Park, M., & Nam, H. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0049-y · Cited by 131
Drug-drug interactions prediction based on deep learning and knowledge graph: A review
Luo, H., Yin, W., Wang, J., Zhang, G., Liang, W., Luo, J., & Yan, C. (2024) · iScience · doi:10.1016/j.isci.2024.109148 · Cited by 131
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128
Bean, D. M., Wu, H., Iqbal, E., Dzahini, O., Ibrahim, Z. M., Broadbent, M., Stewart, R., & Dobson, R. J. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-16674-x · Cited by 127
“Adverse drug reactions and indications extracted from drug package inserts were retrieved from SIDER (www.sideeffects.embl.de) 33 on 09/06/2016.”
MethodExtending the small-molecule similarity principle to all levels of biology with the Chemical Checker
Duran-Frigola, M., Pauls, E., Guitart-Pla, O., Bertoni, M., Alcalde, V., Amat, D., Juan-Blanco, T., & Aloy, P. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0502-7 · Cited by 126
Machine learning methods, databases and tools for drug combination prediction
Wu, L., Wen, Y., Leng, D., Zhang, Q., Dai, C., Wang, Z., Liu, Z., Yan, B., Zhang, Y., Wang, J., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab355 · Cited by 126
A global network of biomedical relationships derived from text
Percha, B., & Altman, R. B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty114 · Cited by 125
Jain, S., Siramshetty, V. B., Alves, V. M., Muratov, E. N., Kleinstreuer, N., Tropsha, A., Nicklaus, M. C., Simeonov, A. M., & Zakharov, A. V. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01164 · Cited by 125
Using artificial intelligence methods to speed up drug discovery
Álvarez-Machancoses, Ó., & Fernández-Martínez, J. L. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1621284 · Cited by 124
Application of Artificial Intelligence in Drug–Drug Interactions Prediction: A Review
Zhang, Y., Deng, Z., Xu, X., Feng, Y., & Shang, J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00582 · Cited by 124
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Tanoli, Z., Fernández‐Torras, A., Özcan, U. O., Kushnir, A., Nader, K. M., Gadiya, Y., Fiorenza, L., Ianevski, A., Vähä-Koskela, M. J. V., Miihkinen, M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01164-x · Cited by 123
Towards a mechanistic understanding of reciprocal drug–microbiome interactions
Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010116 · Cited by 121
The impact of in silico screening in the discovery of novel and safer drug candidates
Rognan, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.034 · Cited by 120
COMETA: A Corpus for Medical Entity Linking in the Social Media
Basaldella, M., Liu, F., Shareghi, E., & Collier, N. (2020) · Conference on Empirical Methods in Natural Language Processing (EMNLP) · doi:10.18653/v1/2020.emnlp-main.253 · Cited by 118
ADVERPred–Web Service for Prediction of Adverse Effects of Drugs
Ivanov, S. M., Lagunin, A. A., Rudik, A. V., Filimonov, D. A., & Poroikov, V. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00568 · Cited by 117
Sun, M., Xing, J., Wang, H., Chen, B., & Zhou, J. (2021) · Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining · doi:10.1145/3447548.3467186 · Cited by 116
Computational drug repositioning based on multi-similarities bilinear matrix factorization
Yang, M., Wu, G., Zhao, Q., Li, Y., & Wang, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa267 · Cited by 114
Christopoulou, F., Tran, T. T., Sahu, S. K., Miwa, M., & Ananiadou, S. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocz101 · Cited by 113
The 2016 database issue ofNucleic Acids Researchand an updated molecular biology database collection
Rigden, D. J., Fernández, X. M., & Galperin, M. Y. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1356 · Cited by 112
DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules
Kropiwnicki, E., Lachmann, A., Clarke, D. J. B., Xie, Z., Jagodnik, K. M., & Ma’ayan, A. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04590-5 · Cited by 111
Drug–drug interaction prediction: databases, web servers and computational models
Zhao, Y. F., Yin, J., Zhang, L., Zhang, Y., & Chen, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad445 · Cited by 110
Magdy, T., Schuldt, A. J. T., Wu, J. C., Bernstein, D., & Burridge, P. W. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-053110 · Cited by 109
Coverage bias in small molecule machine learning
Kretschmer, F., Seipp, J., Ludwig, M., Klau, G. W., & Böcker, S. (2025) · Nature Communications · doi:10.1038/s41467-024-55462-w · Cited by 108
Meta Learning With Graph Attention Networks for Low-Data Drug Discovery
Lv, Q., Chen, G., Yang, Z., Zhong, W., & Chen, C. Y.-C. (2024) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2023.3250324 · Cited by 106
Sosa, D. N., Derry, A., Guo, M., Wei, E., Brinton, C., & Altman, R. B. (2019) · Biocomputing 2020 · doi:10.1142/9789811215636_0041 · Cited by 105
SuperDRUG2: a one stop resource for approved/marketed drugs
Siramshetty, V. B., Eckert, O. A., Gohlke, B.-O., Goede, A., Chen, Q., Devarakonda, P., Preißner, S., & Preißner, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1088 · Cited by 104
Property-Aware Relation Networks for Few-Shot Molecular Property PredictionPreprint
Wang, Y., Abuduweili, A., Yao, Q., & Dou, D. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2107.07994 · Cited by 104
ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18
Chen, Z., Jiang, Y., Zhang, X., Zheng, R., Qiu, R., Sun, Y., Zhao, C., & Shang, H. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab503 · Cited by 102
Revealing Drug-Target Interactions with Computational Models and Algorithms
Zhou, L., Li, Z., Yang, J., Tian, G., Liu, F., Wen, H., Li, P., Chen, M., Xiang, J., & Peng, L. (2019) · Molecules · doi:10.3390/molecules24091714 · Cited by 102
Applied Artificial Intelligence in Materials Science and Material Design
Chávez‐Ángel, E., Eriksen, M., Castro‐Álvarez, A., García, J. H., Botifoll, M., Ávalos‐Ovando, Ó., Arbiol, J., & Mugarza, A. (2025) · Advanced Intelligent Systems · doi:10.1002/aisy.202400986 · Cited by 100
Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
Kingsmore, K. M., Grammer, A. C., & Lipsky, P. E. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0337-0 · Cited by 100
Qiao, J., Jin, J., Wang, D., Teng, S., Zhang, J., Yang, X., Liu, Y., Wang, Y., Cui, L., Zou, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59634-0 · Cited by 99
Proceedings of the 18th BioNLP Workshop and Shared Task
(2019) · doi:10.18653/v1/w19-50 · Cited by 97
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
Pawar, G. V., Madden, J. C., Ebbrell, D. J., Firman, J. W., & Cronin, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00561 · Cited by 97
Zhao, K., & So, H. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2856535 · Cited by 96
Li, X., Lin, L., Pang, L., Pu, K., Fu, J., Shen, Y., Zhang, W., Xu, H., & Niu, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119480 · Cited by 96
FedGraphNN: A Federated Learning System and Benchmark for Graph Neural Networks
He, C., Balasubramanian, K., Ceyani, E., Yang, C., Xie, H., Sun, L., He, L., Yang, L., Yu, P. S., Rong, Y., et al. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2104.07145 · Cited by 95
Gao, Z., Chen, Y., Cai, X., & Xu, R. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btw713 · Cited by 95
A neural network-based method for polypharmacy side effects prediction
Masumshah, R., Aghdam, R., & Eslahchi, C. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04298-y · Cited by 95
Ma, Y., & Tang, J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108924184 · Cited by 94
Systems biology based drug repositioning for development of cancer therapy
Turanlı, B., Altay, Ö., Borén, J., Türkez, H., Nielsen, J., Uhlén, M., Arğa, K. Y., & Mardinoğlu, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.020 · Cited by 92
Zhang, Y., Sheng, M., Zhou, R., Wang, Y., Han, G., Zhang, H., Xing, C., & Dong, J. (2020) · Information Processing & Management · doi:10.1016/j.ipm.2020.102324 · Cited by 92
Neural network-based approaches for biomedical relation classification: A review
Zhang, Y., Lin, H., Yang, Z., Wang, J., Sun, Y., Xu, B., & Zhao, Z. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103294 · Cited by 92
Prediction of adverse drug reactions based on knowledge graph embedding
Zhang, F., Sun, B., Diao, X., Zhao, W., & Shu, T. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01402-3 · Cited by 92
Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning
Miao, R., Xia, L.-Y., Chen, H.-H., Huang, H.-H., & Liang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-44773-4 · Cited by 91
Transformers for Molecular Property Prediction: Lessons Learned from the Past Five Years
Sultan, A., Sieg, J., Mathea, M., & Volkamer, A. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00747 · Cited by 91
Drug repositioning of herbal compounds via a machine-learning approach
Kim, E., Choi, A.-S., & Nam, H. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2811-8 · Cited by 91
Drug Hypersensitivity: Diagnosis, Genetics, and Prevention
Böhm, R., Proksch, E., Schwarz, T., & Cascorbi, I. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0501 · Cited by 90
Vitali, F., Cohen, L. D., Demartini, A., Amato, A. M., Eterno, V., Zambelli, A., & Bellazzi, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162407 · Cited by 90
Predicting drug–drug interactions by graph convolutional network with multi-kernel
Wang, F., Lei, X., Liao, B., & Wu, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab511 · Cited by 89
Kim, H., Lee, J., Ahn, S., & Lee, J. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90259-7 · Cited by 89
Metapath-aggregated heterogeneous graph neural network for drug–target interaction prediction
Li, M., Cai, X., Xu, S., & Ji, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac578 · Cited by 88
Few-shot Molecular Property Prediction via Hierarchically Structured Learning on Relation Graphs
Ju, W., Liu, Z., Qin, Y., Feng, B., Wang, C., Guo, Z., Luo, X., & Zhang, M. (2023) · Neural Networks · doi:10.1016/j.neunet.2023.03.034 · Cited by 86
Prediction of drug adverse events using deep learning in pharmaceutical discovery
Lee, C. Y., & Chen, Y. P. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa040 · Cited by 86
Degradable polyprodrugs: design and therapeutic efficiency
Seidi, F., Zhong, Y., Xiao, H., Jin, Y., & Crespy, D. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00099g · Cited by 85
Prediction of drug-target interactions based on multi-layer network representation learning
Shang, Y., Gao, L., Zou, Q., & Yu, L. (2020) · Neurocomputing · doi:10.1016/j.neucom.2020.12.068 · Cited by 85
Drug repositioning through integration of prior knowledge and projections of drugs and diseases
Xuan, P., Cao, Y., Zhang, T., Wang, X., Pan, S., & Shen, T. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz182 · Cited by 83
Artificial Intelligence-Driven Drug Toxicity Prediction: Advances, Challenges, and Future Directions
Zhang, R., Wen, H., Lin, Z., Li, B., & Zhou, X. (2025) · Toxics · doi:10.3390/toxics13070525 · Cited by 83
Mining Social Media Data for Biomedical Signals and Health-Related Behavior
Correia, R. B., Wood, I. B., Bollen, J., & Rocha, L. M. (2020) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-030320-040844 · Cited by 84
SELFormer: molecular representation learning via SELFIES language models
Yüksel, A., Ulusoy, E., Ünlü, A., & Doğan, T. (2023) · Machine Learning: Science and Technology · doi:10.1088/2632-2153/acdb30 · Cited by 81
Artificial Intelligence in Drug Treatment
Romm, E. L., & Tsigelny, I. F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023746 · Cited by 81
Enhancing Activity Prediction Models in Drug Discovery with the Ability to Understand Human LanguagePreprint
Seidl, P., Vall, A., Hochreiter, S., & Klambauer, G. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2303.03363 · Cited by 81
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Wu, L., Ingle, T., Liu, Z., Zhao-Wong, A., Harris, S., Thakkar, S., Zhou, G., Yang, J., Xu, J., Mehta, D., et al. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2628-5 · Cited by 80
NEDD: a network embedding based method for predicting drug-disease associations
Zhou, R., Lu, Z., Luo, H., Xiang, J., Zeng, M., & Li, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03682-4 · Cited by 80
Artificial neural networks in contemporary toxicology research
Pantic, I. V., Paunović-Pantić, J., Cumic, J., Valjarević, S., Petroianu, G. A., & Corridon, P. R. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110269 · Cited by 80
Zheng, Y., Peng, H., Zhang, X., Zhao, Z., Gao, X., & Li, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3214-6 · Cited by 79
Simpson, J. B., Walker, M. E., Sekela, J. J., Ivey, S. M., Jariwala, P. B., Storch, C. M., Kowalewski, M. E., Graboski, A. L., Lietzan, A. D., Walton, W. G., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.04.018 · Cited by 78
Ietswaart, R., Arat, S., Chen, A. X., Farahmand, S., Kim, B., DuMouchel, W., Armstrong, D., Fekete, A., Sutherland, J. J., & Urban, L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102837 · Cited by 78
Hong, L., Lin, J., Li, S., Wan, F., Yang, H. M., Jiang, T., Zhao, D. Y., & Zeng, J. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0189-y · Cited by 77
Jaganathan, K., Tayara, H., & Chong, K. T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040832 · Cited by 77
Recent advances in AI-based toxicity prediction for drug discovery
Lee, H., Kim, J., Kim, J.-W., & Lee, Y. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1632046 · Cited by 76
Computational drug repurposing based on electronic health records: a scoping review
Zong, N., Wen, A., Moon, S., Fu, S., Wang, L., Zhao, Y., Yu, Y. S., Huang, M. S., Wang, Y., Zheng, G., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00617-6 · Cited by 76
Muñoz, E., Nováček, V., & Vandenbussche, P.-Y. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx099 · Cited by 76
Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney
Eales, J., Jiang, X., Xu, X., Saluja, S., Akbarov, A., Cano-Gamez, E., McNulty, M. T., Finan, C., Guo, H., Wystrychowski, W., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00835-w · Cited by 76
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
Readhead, B., Hartley, B. J., Eastwood, B. J., Collier, D. A., Evans, D., Farias, R., He, C., Hoffman, G., Sklar, P., Dudley, J. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06515-4 · Cited by 75
Systems pharmacology approaches in herbal medicine research: a brief review
Lee, M., Shin, H., Park, M., Kim, A., Cha, S., & Lee, H. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.9.102 · Cited by 75
Gene expression‐based drug repurposing to target aging
Dönertaş, H. M., Fuentealba Valenzuela, M., Partridge, L., & Thornton, J. M. (2018) · Aging Cell · doi:10.1111/acel.12819 · Cited by 73
Knowledge-driven drug repurposing using a comprehensive drug knowledge graph
Zhu, Y., Che, C., Jin, B., Zhang, N., Su, C., & Wang, F. (2020) · Health Informatics Journal · doi:10.1177/1460458220937101 · Cited by 73
Integrating the gut microbiome and pharmacology
Verdegaal, A. A., & Goodman, A. L. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8357 · Cited by 72
Signature-based approaches for informed drug repurposing: targeting CNS disorders
Shukla, R., Henkel, N., Alganem, K., Hamoud, A.-R. A., Reigle, J. K., Alnafisah, R. S., Eby, H., Imami, A. S., Creeden, J. F., Miruzzi, S. A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0752-6 · Cited by 72
A scoping review of artificial intelligence applications in clinical trial risk assessment
Teodoro, D., Naderi, N., Yazdani, A., Zhang, B., & Bornet, A. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01886-7 · Cited by 72
Chartier, M., Morency, L.-P., Zylber, M. I., & Najmanovich, R. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0128-7 · Cited by 72
Gudala, M., Ross, M. E. T., Mogalla, S., Lyons, M., Ramaswamy, P., & Roberts, K. (2022) · JMIR Aging · doi:10.2196/32169 · Cited by 71
Wu, P., Feng, Q., Kerchberger, V. E., Nelson, S. D., Chen, Q., Li, B., Edwards, T. L., Cox, N. J., Phillips, E. J., Stein, C. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27751-1 · Cited by 71
Web-based drug repurposing tools: a survey
Sam, E., & Athri, P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx125 · Cited by 70
DeepSide: A Deep Learning Approach for Drug Side Effect Prediction
Uner, O. C., Kuru, H. İ., Cinbiş, R. G., Taştan, Ö., & Çiçek, A. E. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3141103 · Cited by 70
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
Wooden, B., Goossens, N., Hoshida, Y., & Friedman, S. L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.065 · Cited by 69
Interpretable machine learning for materials design
Dean, J., Scheffler, M., Purcell, T. A. R., Barabash, S. V., Bhowmik, R., & Bazhirov, T. (2023) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-023-01164-w · Cited by 69
Ji, X., Tong, W., Liu, Z., & Shi, T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00600 · Cited by 69
Ren, Z.-H., Yu, C.-Q., Li, L., You, Z., Guan, Y.-J., Wang, X., & Pan, J. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac004 · Cited by 69
A network embedding framework based on integrating multiplex network for drug combination prediction
Yu, L., Xia, M., & An, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab364 · Cited by 69
A dataset of 200 structured product labels annotated for adverse drug reactions
Demner-Fushman, D., Shooshan, S. E., Rodriguez, L., Aronson, A. R., Lang, F., Rogers, W., Roberts, K., & Tonning, J. (2018) · Scientific Data · doi:10.1038/sdata.2018.1 · Cited by 68
Few-Shot Learning for Low-Data Drug Discovery
Vella, D., & Ebejer, J.-P. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00779 · Cited by 68
The side effect profile of Clozapine in real world data of three large mental health hospitals
Iqbal, E., Govind, R., Romero, A., Dzahini, O., Broadbent, M. T. M., Stewart, R. J., Smith, T. D., Kim, C.-H., Werbeloff, N., MacCabe, J. H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243437 · Cited by 68
Raja, K., Patrick, M., Elder, J. T., & Tsoi, L. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-03914-3 · Cited by 67
Computational Drug Repositioning: Current Progress and Challenges
Ko, Y. (2020) · Applied Sciences · doi:10.3390/app10155076 · Cited by 67
ReLMole: Molecular Representation Learning Based on Two-Level Graph Similarities
Ji, Z., Shi, R., Lu, J., Li, F., & Yang, Y. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00798 · Cited by 67
Aliper, A., Belikov, A. V., Garazha, A., Jellen, L., Artemov, A., Suntsova, M., Ivanova, A., Venkova, L., Borisov, N., Buzdin, A., et al. (2016) · Aging · doi:10.18632/aging.101047 · Cited by 66
Joshi, P., Masilamani, V., & Mukherjee, A. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104122 · Cited by 66
Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review
Davis, S. E., Zabotka, L. E., Desai, R. J., Wang, S. V., Maro, J. C., Coughlin, K., Hernández‐Muñoz, J. J., Stojanović, D., Shah, N. H., & Smith, J. (2023) · Drug Safety · doi:10.1007/s40264-023-01325-0 · Cited by 66
Metadata
- Authors
- Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Copenhagen (DK)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-19
- Volume
- 44
- Issue
- D1
- Pages
- D1075-D1079
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702794
- OpenAlex
- W2145578524
- Cited by
- 1,451
- References
- 18
- Citations by year
- 2026: 123 · 2025: 199 · 2024: 194 · 2023: 160 · 2022: 156 · 2021: 183 · 2020: 131 · 2019: 111 · 2018: 82 · 2017: 74 · 2016: 37
- FWCI
- 51.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Molecular Biology Laboratory
- Novo Nordisk (NNF14CC0001)
- Novo Nordisk Fonden (NNF 14CC0001)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- SIDER, adverse drug reactions, drug safety, drug indications, package inserts, natural language processing, therapeutic target
- MeSH terms
- Drug Labeling, Internet, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.